Genstar Capital-backed Advarra completed the acquisition of Bio-Optronics.

Genstar Capital-backed Advarra, a global technology provider for clinical research sites, completed the acquisition of Bio-Optronics, a healthcare IT company, focusing specifically on workflow optimization. Financial terms were not disclosed. “The addition of CCTrialSuite and Bio-Optronics’ global customer base enhances Advarra’s technology portfolio and further solidifies our position as the de-facto standard for clinical research site technology,” Gadi Saarony, Advarra CEO.